Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A phase III randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of PRM-151 in patients with idiopathic pulmonary fibrosis

This study will evaluate the effectiveness and safety of study drug PRM-151 compared with placebo in patients with idiopathic pulmonary fibrosis
Timothy Sheehan at tsheehan@pennstatehealth.psu.edu or 717-531-2925
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04552899
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
Adults 40
•85 years of age
Diagnosis of Idiopathic Pulmonary Fibrosis
Exclusion Criteria:
Taking both nintedanib and pirfenidone
Receiving prednisone >10mg daily
Using more than 4 liters of oxygen/min
Lung Disease & Asthma
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA